Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / Feb / Also in the News… (1)
Research & Innovations Anterior Segment Cornea Glaucoma Retina

Also in the News…

From AI algorithms for home-based OCT to new indications for Susvimo, these are the news stories and studies that caught our attention this week…

By Alun Evans 2/14/2025 1 min read

Share

Lokilech, CC BY-SA 3.0 <http://creativecommons.org/licenses/by-sa/3.0/>, via Wikimedia Commons

AI algorithm for at-home OCT. Notal Vision has announced the results of a pivotal study evaluating the performance of an artificial intelligence (AI) algorithm for the estimation of key biomarkers in neovascular AMD using a home-based optical coherence tomography (OCT) system. Link

New indication for Susvimo. Roche’s wet age-related macular degeneration (AMD) treatment, Susvimo (ranibizumab injection), has gained FDA approval for the treatment of diabetic macular oedema (DME) patients. The new indication approval comes after the company voluntarily recalled the injection back in 2022 due to manufacturing concerns, before reintroducing it to market in July 2024. Link

Link between hs-CRP, RAO, and ischaemic stroke. A recent British Journal of Ophthalmology study has shown that elevated high-sensitivity C-reactive protein (hs-CRP) levels are significantly associated with an increased risk of both retinal artery occlusion (RAO) and ischemic stroke (IS). Link

Retinal fluid and nAMD. An Ophthalmology & Therapy review exploring the role of subretinal fluid (SRF) and intraretinal fluid (IRF) in neovascular age-related macular degeneration (nAMD) concludes that IRF should be treated aggressively because it is associated with poorer visual outcomes, whereas mild SRF may be tolerated without significantly affecting vision – potentially even providing protective effects against macular atrophy and fibrosis. Link

3D Printing for Retinal Implants. Researchers from RWTH Aachen University have developed the 3D-printed large-array port-system (3D-PLAPS) to improve the surgical implantation of large epiretinal stimulators for retinitis pigmentosa (RP). The device stabilizes intraocular pressure (IOP), seals the incision site, and enables precise, controlled implantation of very large electrode arrays (VLARS), reducing surgical trauma. Though further in vivo testing is needed, the study demonstrates that 3D-PLAPS can be implanted and removed safely without compromising ocular integrity. Link

About the Author(s)

Alun Evans

More Articles by Alun Evans

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: